Abstract
The aim of this study was the search of permanent proteins of the urinary proteome during a 520-day isolation experiment at the Institute of Biomedical Problems (IBMP) Ground-Based Test Facility in controlled conditions, using an autonomous life support system. The object of the study was urine sampled from 6 normal male subjects aged 25 to 37. The biological material samples (the second morning urine fractions) were collected for proteomic investigations against the background, on the 50th, 93rd, 124th, 153rd, 180th, 251st, 274th, 303rd, 330th, 371st, 400th, and 427th days of isolation, and on the 7th day after its completion. The samples were analyzed using chromatography–mass spectrometry, while the obtained results were analyzed using bioinformatics resources. The following seven permanent proteins were identified and observed during the entire period of urine investigations: epidermal growth factor, polymeric immunoglobulin receptor, plasma serine protease inhibitor, Alpha 1 microglobulin/bikunin precursor (AMBP), keratin (type II cytoskeletal 1), collagen alpha-1 (VI) chain, and serum albumin.
Similar content being viewed by others
References
Agron, I.A., Avtonomov, D.M., Kononikhin, A.S., et al., Accurate mass tag retention time database for urine proteome analysis by chromatography-mass spectrometry, Biochemistry, 2010, vol. 75, no. 5, pp. 636.
Babichenko, I.I. and Kovyazin, V.A., Novye metody immunogistokhimicheskoi diagnostiki opukholevogo rosta (New Methods of Tumor Growth by Immunohistochemical Diagnostics), Moscow, 2008.
Adachi, J., Kumar, C., Zhang, Y., et al., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins, Genome Biol., 2006, vol. 7, no. 9, p. R80.
Albalat, A., Mischak, H., and Mullen, W., Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation, Prilozi, 2011, vol. 32, no. 1, pp. 13.
Allhorn, M., Berggård, T., Nordberg, J., et al., Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties, Blood, 2002, vol. 15, no. 99, pp. 1894.
Christensen, E.I. and Gburek, J., Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology, Pediatr. Nephrol., 2004, vol. 9, no. 7, pp. 714.
Court, M., Selevsek, N., Matondo, M., et al., Toward a standardized urine proteome analysis methodology, Proteomics, 2011, vol. 11, no. 6, pp. 1160.
España, F., Navarro, S., Medina, P., et al., The role of protein C inhibitor in human reproduction, Semin. Thromb. Hemostasis, 2007, vol. 33, no. 1, pp. 41.
Glogowska, A., Stetefeld, J., Weber, E., et al., Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitinproteasome pathway in human cancer cells, Neoplasia, 2012, vol. 14, no. 5, pp. 396.
Hamburger, A.E., West, A.P.Jr., and Bjorkman, P.J., Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor, Structure, 2004, vol. 12, no. 11, pp. 1925.
Igci, M., Arslan, A., Igci, Y.Z., et al., Bikunin and a1-microglobulin/bikunin precursor (AMBP) gene mutational screening in patients with kidney stones: a casecontrol study, Scand. J. Urol. Nephrol., 2010, vol. 44, no. 6, pp. 413.
Ishihama, Y., Rappsilber, J., Andersen, J.S., and Mann, M., Microcolumns with self-assembled particle frits for proteomics, J. Chromatogr., A, 2002, vol. 979, nos. 1–2, p. 233.
Ishikawa, H., Sugie, K., Murayama, K., et al., Ullrich disease due to deficiency of collagen VI in the sarcolemma, Neurology, 2004, vol. 62, no. 4, pp. 620.
Kuritzky, L., Toto, R., and Van Buren, P., Identification and management of albuminuria in the primary care setting, J. Clin. Hypertens., 2011, vol. 13, no. 6, pp. 438.
Lampe, A.K. and Bushby, K.M., Collagen VI related muscle disorders, J. Med. Genet., 2005, vol. 42, no. 9, pp. 673.
Lei, T., Zhao, X., Jin, S., et al., Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis, Clin. Genitourin. Cancer, 2013, vol. 11, no. 1, pp. 56.
Malmström, E., Mörgelin, M., Malmsten, M., et al., Protein c inhibitor—a novel antimicrobial agent, PLoS Pathog., 2009, vol. 5, no. 12, p. e1000698.
Nagaraj, N. and Mann, M., Quantitative analysis of the intra-and inter-individual variability of the normal urinary proteome, J. Proteome Res., 2011, vol. 10, no. 2, pp. 637.
Rouet, P., Raguenez, G., Ruminy, P., and Salier, J.P., An array of binding sites for hepatocyte nuclear factor 4 of high and low affinities modulates the liver-specific enhancer for the human alpha1-microglobulin/bikunin precursor, Biochem. J., 1998, vol. 15, no. 334, pp. 577.
Schweizer, J., Bowden, P.E., Coulombe, P.A., et al., New consensus nomenclature for mammalian keratins, J. Cell Biol., 2006, vol. 174, no. 2, pp. 169.
Tan, Y., Zhang, J.J., Liu, G., et al., The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes, Clin. Exp. Immunol., 2009, vol. 156, no. 1, pp. 111.
Thulesen, J., Jørgensen, P.E., Torffvit, O., et al., Urinary excretion of epidermal growth factor and Tamm-Horsfall protein in three rat models with increased renal excretion of urine, Regul. Pept., 1997, vol. 72, nos. 2–3, p. 179.
Tojo, A. and Kinugasa, S., Mechanisms of glomerular albumin filtration and tubular reabsorption, Int. J. Nephrol., 2012. http://www.hindawi.com/journals/ijn/2012/481520/.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.Kh. Pastushkova, K.S. Kireev, A.S. Kononikhin, E.S. Tiys, I.A. Popov, I.V. Dobrokhotov, M.-A. Custaud, V.A. Ivanisenko, N.A. Kolchanov, E.N. Nikolaev, V.I. Pochuev, I.M. Larina, 2014, published in Aviakosmicheskaya i Ekologicheskaya Meditsina, 2014, Vol. 48, No. 1, pp. 48–54.
Rights and permissions
About this article
Cite this article
Pastushkova, L.K., Kireev, K.S., Kononikhin, A.S. et al. Constant urinary proteins in healthy humans in a 520-day isolation experiment. Hum Physiol 42, 760–765 (2016). https://doi.org/10.1134/S0362119716070136
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0362119716070136